{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:56:08Z","timestamp":1791428168188,"version":"4.3.3"},"reference-count":17,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Adhesions commonly occur after abdominal and pelvic surgery, causing infertility, intestinal obstruction, and pelvic pain. Existing anti-adhesion materials are often difficult to use on uneven organ surfaces, highlighting the need for novel solutions; SI-449, a cross-linked, powder-formed chondroitin sulfate (CS), may address these limitations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the anti-adhesion effect of the SI-449 adhesion barrier system (cs barrier) in patients undergoing open rectal resection for rectal cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This multicenter, prospective, randomized, open, and blinded\u2013end point (PROBE) method pivotal clinical trial was conducted at 53 hospitals in Japan from September 2020 to June 2023. The study participants and efficacy assessors on the central review board were blinded. Patients aged 20 years or older with clinical stage I through IV rectal cancer who underwent open rectal resection and were scheduled for follow-up ileostomy closure were eligible for inclusion. Data were analyzed from July 2023 through September 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>The control group received no additional procedure before abdominal closure, while the experimental group received 2 to 3 g of SI-449 applied to the abdominal or pelvic cavity immediately before closure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary end point was the incidence of adhesions under the incision. Secondary end points included adhesion number, severity, and extent; number and type of adhered organs; and number of adhesions per organ. Safety and operability were also evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 155 screened patients, 131 met the inclusion criteria and were randomized. Of these, 128 underwent the intervention (safety analysis population; control group: n\u2009=\u200964; experimental group: n\u2009=\u200964), and 118 completed a second surgery (modified intention-to-treat population; control group: n\u2009=\u200960; experimental group: n\u2009=\u200958). Overall mean (SD) patient age was 68.2 (10.3) years, and 34 patients of 118 (29%) were female. Adhesion incidence was significantly lower in the experimental group (26 of 58 [45%]) compared to the control group (56 of 60 [93%]) (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). The experimental group also showed significantly reduced adhesion severity and extent. No safety concerns were identified, and operability was good.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this randomized clinical trial, SI-449 in the powdered form reduced the incidence of adhesions, and the adhesion barrier system had good operability and no safety concerns. Thus, this system may provide a new anti-adhesion option for use in open surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      jrct.mhlw.go.jp Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/jrct.mhlw.go.jp\/en-latest-detail\/jRCT1080225247\">jRCT1080225247<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamasurg.2026.3416","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:30:44Z","timestamp":1787758244000},"page":"985","source":"Crossref","is-referenced-by-count":1,"title":["Cross-Linked Chondroitin Sulfate Adhesion Barrier System in Open Rectal Resection"],"prefix":"10.1001","volume":"161","author":[{"given":"Yukihide","family":"Kanemitsu","sequence":"first","affiliation":[{"name":"Department of Colorectal Surgery, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Hashizume","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Nihonkai General Hospital, Sakata, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Suto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Yamagata Prefectural Central Hospital, Yamagata, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Yawata","sequence":"additional","affiliation":[{"name":"Department of Surgery, Gifu Municipal Hospital, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Inaoka","sequence":"additional","affiliation":[{"name":"Department of Surgery, Toyohashi Medical Center, Toyohashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Hiramatsu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Toyohashi Municipal Hospital, Toyohashi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Komori","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Division of Lower GI, Department of Gastroenterological Surgery, Hyogo Medical University, Nishinomiya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Ishido","sequence":"additional","affiliation":[{"name":"Department of Surgery, Japanese Red Cross Kobe Hospital, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Kitasato University Kitasato Institute Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"soi260049r1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1093\/humupd\/7.6.567","article-title":"Clinical implications of postsurgical adhesions.","volume":"7","author":"Diamond","year":"2001","journal-title":"Hum Reprod Update"},{"issue":"5","key":"soi260049r2","first-page":"345","article-title":"Predictors of pelvic adhesions.","volume":"34","author":"Stovall","year":"1989","journal-title":"J Reprod Med"},{"issue":"44","key":"soi260049r3","first-page":"769","article-title":"Intra-abdominal adhesions: definition, origin, significance in surgical practice, and treatment options.","volume":"107","author":"Br\u00fcggmann","year":"2010","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"soi260049r4","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4103\/0972-9941.18995","article-title":"Role of laparoscopy in evaluation of chronic pelvic pain.","volume":"1","author":"Hebbar","year":"2005","journal-title":"J Minim Access Surg"},{"issue":"6","key":"soi260049r5","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/bjs.5634","article-title":"Long-term follow-up and cost analysis following surgery for small bowel obstruction caused by intra-abdominal adhesions.","volume":"94","author":"Tingstedt","year":"2007","journal-title":"Br J Surg"},{"key":"soi260049r6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1463-1318.2007.01358.x","article-title":"Consequences and complications of peritoneal adhesions.","volume":"9","author":"van Goor","year":"2007","journal-title":"Colorectal Dis"},{"issue":"4","key":"soi260049r7","first-page":"297","article-title":"Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, double-blind multicenter study.","volume":"183","author":"Becker","year":"1996","journal-title":"J Am Coll Surg"},{"issue":"4","key":"soi260049r8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/ags3.12544","article-title":"Safety, efficacy, and operability of a newly developed absorbable adhesion barrier (GM142) in patients with primary rectal cancer scheduled for diverting ileostomy during laparoscopic surgery: randomized controlled trial.","volume":"6","author":"Watanabe","year":"2022","journal-title":"Ann Gastroenterol Surg"},{"issue":"5","key":"soi260049r9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/lap.2006.16.497","article-title":"A novel instrument and technique for using Seprafilm hyaluronic acid\/carboxymethylcellulose membrane during laparoscopic myomectomy.","volume":"16","author":"Takeuchi","year":"2006","journal-title":"J Laparoendosc Adv Surg Tech A"},{"issue":"10","key":"soi260049r10","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s11605-017-3503-1","article-title":"The primary result of prospective randomized multicenter trial of new spray-type bio-absorbable adhesion barrier system (TCD-11091) against postoperative adhesion formation.","volume":"21","author":"Suto","year":"2017","journal-title":"J Gastrointest Surg"},{"key":"soi260049r12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jss.2024.10.016","article-title":"Effects of novel cross-linked chondroitin sulfate (SI-449) as a postoperative anti-adhesion barrier.","volume":"304","author":"Toyama","year":"2024","journal-title":"J Surg Res"},{"issue":"22","key":"soi260049r13","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1001\/jama.2025.4347","article-title":"CONSORT 2025 Statement: updated guideline for reporting randomized trials.","volume":"333","author":"Hopewell","year":"2025","journal-title":"JAMA"},{"issue":"6","key":"soi260049r14","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1007\/s10350-004-0954-8","article-title":"Prevention of postoperative abdominal adhesions by a novel, glycerol\/sodium hyaluronate\/carboxymethylcellulose-based bioresorbable membrane: a prospective, randomized, evaluator-blinded multicenter study.","volume":"48","author":"Cohen","year":"2005","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"soi260049r15","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1097\/SLA.0000000000002175","article-title":"Multicenter observational study of adhesion formation after open-and laparoscopic surgery for colorectal cancer.","volume":"267","author":"Stommel","year":"2018","journal-title":"Ann Surg"},{"issue":"2","key":"soi260049r16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/01.sla.0000132988.50122.de","article-title":"Long-term prognosis after operation for adhesive small bowel obstruction.","volume":"240","author":"Fevang","year":"2004","journal-title":"Ann Surg"},{"key":"soi260049r17","doi-asserted-by":"publisher","first-page":"f5588","DOI":"10.1136\/bmj.f5588","article-title":"Burden of adhesions in abdominal and pelvic surgery: systematic review and met-analysis.","volume":"347","author":"ten Broek","year":"2013","journal-title":"BMJ"},{"key":"soi260049r11","unstructured":"Usage of biocompatible surgical materials and the usefulness of new materials. 1st ed. Gijutsu Joho Kyokai Co. 2024:3-5. https:\/\/www.gijutu.co.jp\/doc\/b_2239.htm"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2853288\/jamasurgery_kanemitsu_2026_oi_260049_1791304727.73742.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:00:56Z","timestamp":1791385256000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2853288"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2026.3416","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,1]]}}}